Published in EMBO J on July 01, 1987
High-level transcription from the adenovirus major late promoter requires downstream binding sites for late-phase-specific factors. J Virol (1990) 1.34
Analysis of the specificity and mechanism of transcriptional activation of the human hsp70 gene during infection by DNA viruses. J Virol (1991) 1.28
Transcriptional analysis of minute virus of mice P4 promoter mutants. J Virol (1989) 1.27
Multiple transcription factors interact with the adenovirus-2 EII-late promoter: evidence for a novel CCAAT recognition factor. Nucleic Acids Res (1987) 1.15
The adenovirus EII early promoter has multiple EIA-sensitive elements, two of which function cooperatively in basal and virus-induced transcription. J Virol (1990) 0.93
Adenovirus late-phase infection is controlled by a novel L4 promoter. J Virol (2010) 0.93
cis-dominant defect in activation of adenovirus type 5 E1b early RNA synthesis. J Virol (1990) 0.87
Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway. J Virol (2001) 0.87
Cloning and characterization of the mouse vitamin D receptor promoter. Proc Natl Acad Sci U S A (1997) 0.84
Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genome. J Virol (2010) 0.77
Delineation of DNA sequences that are important for in vitro transcription from the adenovirus EIIa late promoter. Mol Cell Biol (1988) 0.75
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem (1981) 49.46
Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates. Nucleic Acids Res (1979) 31.23
DNAse footprinting: a simple method for the detection of protein-DNA binding specificity. Nucleic Acids Res (1978) 30.43
Transcriptional control signals of a eukaryotic protein-coding gene. Science (1982) 25.38
Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci U S A (1978) 19.34
Affinity purification of sequence-specific DNA binding proteins. Proc Natl Acad Sci U S A (1986) 14.92
Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell (1985) 13.36
An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci U S A (1979) 13.21
Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell (1979) 12.83
Enhancer elements. Cell (1983) 10.41
Identification of DNA sequences required for transcription of the human alpha 1-globin gene in a new SV40 host-vector system. Cell (1981) 9.81
Three regions upstream from the cap site are required for efficient and accurate transcription of the rabbit beta-globin gene in mouse 3T6 cells. Cell (1983) 9.51
Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell (1981) 9.38
Identification of procollagen mRNAs transferred to diazobenzyloxymethyl paper from formaldehyde agarose gels. Nucleic Acids Res (1979) 9.33
The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell (1983) 8.19
Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science (1986) 8.01
Transcriptional selectivity of viral genes in mammalian cells. Cell (1986) 7.95
A Drosophila RNA polymerase II transcription factor contains a promoter-region-specific DNA-binding activity. Cell (1984) 7.69
Complex splicing patterns of RNAs from the early regions of adenovirus-2. J Mol Biol (1979) 7.53
Formation of stable preinitiation complexes between eukaryotic class B transcription factors and promoter sequences. Nature (1983) 7.22
Identification of a cellular transcription factor involved in E1A trans-activation. Cell (1986) 6.36
Promoters and heterogeneous 5' termini of the messenger RNAs of adenovirus serotype 2. J Mol Biol (1981) 5.01
Complete transformation by adenovirus 2 requires both E1A proteins. Cell (1984) 3.80
Identification of the gene and mRNA for the adenovirus terminal protein precursor. Cell (1981) 3.39
Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis. J Virol (1981) 3.36
Adenovirus EIIA early promoter: transcriptional control elements and induction by the viral pre-early EIA gene, which appears to be sequence independent. Proc Natl Acad Sci U S A (1985) 3.32
DNA replication and the early to late transition in adenovirus infection. Cell (1980) 3.17
Cis-acting induction of adenovirus transcription. Cell (1983) 3.05
The adenovirus-2 early EIIa transcription unit possesses two overlapping promoters with different sequence requirements for EIa-dependent stimulation. EMBO J (1985) 2.89
Identification of a factor in HeLa cells specific for an upstream transcriptional control sequence of an EIA-inducible adenovirus promoter and its relative abundance in infected and uninfected cells. Proc Natl Acad Sci U S A (1986) 2.81
In vitro stimulation of specific RNA polymerase II-mediated transcription by the pseudorabies virus immediate early protein. Cell (1985) 1.46
Two functions encoded by adenovirus early region 1A are responsible for the activation and repression of the DNA-binding protein gene. EMBO J (1985) 1.35
Adenovirus early region 1A protein increases the number of template molecules transcribed in cell-free extracts. Proc Natl Acad Sci U S A (1986) 1.23
Sequence-specific activation of transcription by adenovirus EIa products is observed in HeLa cells but not in 293 cells. Mol Cell Biol (1986) 1.05
Suppression of the translation defect phenotype specific for a virus-associated RNA-deficient adenovirus mutant in monkey cells by simian virus 40. J Virol (1986) 0.92
The genome of simian virus 40. Science (1978) 24.46
Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell (1982) 5.80
Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell (1986) 4.72
A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promoters. Proc Natl Acad Sci U S A (1987) 3.91
AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans (2003) 3.72
Adenovirus EIIA early promoter: transcriptional control elements and induction by the viral pre-early EIA gene, which appears to be sequence independent. Proc Natl Acad Sci U S A (1985) 3.32
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest (1999) 2.91
Identification of a factor in HeLa cells specific for an upstream transcriptional control sequence of an EIA-inducible adenovirus promoter and its relative abundance in infected and uninfected cells. Proc Natl Acad Sci U S A (1986) 2.81
Viral-encoded small RNAs in herpes virus saimiri induced tumors. EMBO J (1986) 2.60
Nucleotide sequence analysis of viable deletion mutants lacking segments of the simian virus 40 genome coding for small t antigen. J Virol (1979) 2.28
NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A. J Virol (1992) 2.10
The early region of SV40 DNA may have more than one gene. Cell (1977) 2.09
Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5. Proc Natl Acad Sci U S A (1983) 2.06
Two promoter-specific host factors interact with adjacent sequences in an EIA-inducible adenovirus promoter. Proc Natl Acad Sci U S A (1987) 1.95
Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis (2000) 1.95
Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus. J Virol (1985) 1.79
A mutation which alters initiation of transcription by RNA polymerase III on the Ad5 chromosome. Cell (1979) 1.75
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J Clin Oncol (1991) 1.61
SV40 mutant tsA1499 is heat-sensitive for lytic growth but generates cold-sensitive rat-cell transformants. Cold Spring Harb Symp Quant Biol (1980) 1.52
Complementation of adenovirus virus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor. Proc Natl Acad Sci U S A (1989) 1.51
Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding. Aliment Pharmacol Ther (2006) 1.46
Adenovirus mutants with DNA sequence perturbations in the intragenic promoter of VAI RNA gene allow the enhanced transcription of VAII RNA gene in HeLa cells. Nucleic Acids Res (1984) 1.43
Structural requirements of adenovirus VAI RNA for its translation enhancement function. Mol Cell Biol (1985) 1.30
Partial biochemical characterization of cell surface hydrophobicity and hydrophilicity of Candida albicans. Infect Immun (1990) 1.28
Functional dissection of adenovirus VAI RNA. J Virol (1989) 1.26
Tissue-specific and differentiation-appropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotype. Differentiation (1993) 1.23
CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis. J Neurochem (2001) 1.21
Unique presence of 2-methylthio-ribosylzeatin in the transfer ribonucleic acid of the bacterium Pseudomonas aeruginosa. Biochem Biophys Res Commun (1974) 1.20
The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis. Gastroenterology (2001) 1.17
The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor. Nucleic Acids Res (1990) 1.16
Organization of the noncontiguous promoter components of adenovirus VAI RNA gene is strikingly similar to that of eucaryotic tRNA genes. Mol Cell Biol (1983) 1.14
Increased permeability in dextran sulphate colitis in rats: time course of development and effect of butyrate. Scand J Gastroenterol (2000) 1.13
The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol (2001) 1.13
Involucrin--structure and role in envelope assembly. J Invest Dermatol (1993) 1.12
Generation of hybrid human immunodeficiency virus utilizing the cotransfection method and analysis of cellular tropism. J Virol (1991) 1.10
Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res Hum Retroviruses (1994) 1.06
Evidence that involucrin is a covalently linked constituent of highly purified cultured keratinocyte cornified envelopes. J Invest Dermatol (1993) 0.99
The primary structure of regions of SV 40 DNA encoding the ends of mRNA. Prog Nucleic Acid Res Mol Biol (1976) 0.98
Caveolin is present in intestinal cells: role in cholesterol trafficking? J Lipid Res (1998) 0.96
New pool of cortical interneuron precursors in the early postnatal dorsal white matter. Cereb Cortex (2011) 0.95
Regulation of sterol regulatory element-binding proteins in hamster intestine by changes in cholesterol flux. J Biol Chem (2001) 0.93
Ultrastructural characterization of human immunodeficiency virus type 1 Gag-containing particles assembled in a recombinant adenovirus vector system. J Gen Virol (1991) 0.93
Regulation of sterol regulatory element-binding proteins by cholesterol flux in CaCo-2 cells. J Lipid Res (2001) 0.93
Rank-order of potencies for inhibition of the secretion of abeta40 and abeta42 suggests that both are generated by a single gamma-secretase. J Biol Chem (1999) 0.93
Suppression of the translation defect phenotype specific for a virus-associated RNA-deficient adenovirus mutant in monkey cells by simian virus 40. J Virol (1986) 0.92
Primary tuberculosis of the conjunctiva. Eye (Lond) (2001) 0.92
Nucleotide sequence of the gene for the major structural protein of SV40 virus. Nucleic Acids Res (1977) 0.91
Current practice in administration and clinical criteria of emergent EEG. J Clin Neurophysiol (2001) 0.91
Clinical trial: oral feeding with a soft diet compared with clear liquid diet as initial meal in mild acute pancreatitis. Aliment Pharmacol Ther (2008) 0.90
Nucleotide sequence of DNA template for the 3' ends of SV40 mRNA. II. The sequence of the DNA fragment EcorII-F and a part of EcorII-H. J Biol Chem (1978) 0.89
Breakpoints at 11q23 in infant leukemias with the t(11;19)(q23;p13) are clustered. Blood (1992) 0.89
Five human genes encoding F-box proteins: chromosome mapping and analysis in human tumors. Cytogenet Cell Genet (2000) 0.89
Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma. Cancer Res (1991) 0.88
Hemorrhage from recanalized umbilical vein in a patient with cirrhosis. Am J Gastroenterol (1999) 0.88
A novel testis-specific gene, SPAG4, whose product interacts specifically with outer dense fiber protein ODF27, maps to human chromosome 20q11.2. Cytogenet Cell Genet (1998) 0.87
Regulation of gene expression and synthesis and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by micellar cholesterolin CaCo-2 cells. J Lipid Res (1991) 0.87
Squamous cell carcinoma and adenocarcinoma of the lower third of the esophagus and gastric cardia: similarities and differences. Dis Esophagus (2002) 0.87
Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent parathyroid hormone treatment. J Cell Physiol (2009) 0.87
Going for mainstream deammonification from bench to full scale for maximized resource efficiency. Water Sci Technol (2013) 0.87
Perioperative stimulation of residual cancer cells promotes local and distant recurrence of breast cancer. J Am Coll Surg (1997) 0.86
Transport of cholesterol from the endoplasmic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cholesterol to the endoplasmic reticulum. J Lipid Res (1998) 0.86
An unusual presentation of encysted pleural effusion due to salmonella typhi. J Assoc Physicians India (1982) 0.85
Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in mice. Diabetes (2000) 0.84
Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14. Cancer (1993) 0.84
The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics. Clin Pharmacol Ther (2012) 0.84
Gene expression of sterol regulatory element-binding proteins in hamster small intestine. J Lipid Res (2001) 0.84
Depletion of colonic detoxication enzyme activity in mice with dextran sulphate sodium-induced colitis. Aliment Pharmacol Ther (1999) 0.84
Nucleotide sequences of DNA encoding the 3' ends of SV40 mRNA. I. The sequence of the DNA fragment Hi-DII,III-G. J Biol Chem (1978) 0.83
Effect of CIS on activity in trans of the replication initiator protein of an IncB plasmid. J Bacteriol (2000) 0.83
Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 0.83
Intracranial optic nerve enlargement in infantile Krabbe disease. Neurology (2012) 0.82
A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma. Cancer (1992) 0.82
Regulation of apolipoprotein B secretion by biliary lipids in CaCo-2 cells. J Lipid Res (1994) 0.81
Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects. Cancer Res (1989) 0.81
Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium. Prostate (2001) 0.81
Efficient expression of small RNA polymerase III genes from a novel simian virus 40 vector and their effect on viral gene expression. Nucleic Acids Res (1989) 0.81
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy. J Clin Oncol (1992) 0.81
Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro. J Surg Oncol (1999) 0.80
Microsomal triglyceride transfer protein in CaCo-2 cells: characterization and regulation. J Lipid Res (1997) 0.80
Influencing spermicide use among low-income minority women. J Am Med Womens Assoc (1995) 0.80
Aarskog syndrome: significance for the surgeon. J Pediatr Surg (1979) 0.80
Phase I study of WR-2721 and carboplatin. Eur J Cancer (1993) 0.79
Esterification of plasma membrane cholesterol and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells: possible role of p-glycoprotein. J Lipid Res (1995) 0.79
An open-pored gelatin/hydroxyapatite composite as a potential bone substitute. J Mater Sci Mater Med (2007) 0.79
Expression of the protein kinase p-68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms. Virchows Arch B Cell Pathol Incl Mol Pathol (1992) 0.79
Phosphate complexation model and its implications for chemical phosphorus removal. Water Environ Res (2008) 0.79
Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients. Transpl Infect Dis (2008) 0.78
Imaging biomarkers of inflammation in situ with functionalized quantum dots in the dextran sodium sulfate (DSS) model of mouse colitis. Inflamm Res (2007) 0.78
Phase I trial of dipyridamole with 5-fluorouracil and folinic acid. Cancer Res (1990) 0.78
Ultra-short-acting beta-adrenergic blockers. Med Clin North Am (1988) 0.78
Corneal triple procedure: indications, complications, and outcomes: a developing country scenario. Cornea (2000) 0.78
Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma. J Nucl Med (1996) 0.78
Lysophosphatidylcholine increases the secretion of cholesteryl ester-poor triacylglycerol-rich lipoproteins by CaCo-2 cells. Biochem J (1994) 0.77
Pseudo-mycosis fungoides in a patient taking clonazepam and fluoxetine. J Am Acad Dermatol (1996) 0.77
Quantitative and qualitative effects of bioaugmentation on ammonia oxidisers at a two-step WWTP. Water Sci Technol (2010) 0.77
Phosphatidylcholine increases the secretion of triacylglycerol-rich lipoproteins by CaCo-2 cells. Biochem J (1996) 0.77